GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (LTS:0DHC) » Definitions » Cash Conversion Cycle

Carl Zeiss Meditec AG (LTS:0DHC) Cash Conversion Cycle

: 152.84 (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Carl Zeiss Meditec AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 37.83.
Carl Zeiss Meditec AG's Days Inventory for the three months ended in Dec. 2023 was 213.35.
Carl Zeiss Meditec AG's Days Payable for the three months ended in Dec. 2023 was 98.34.
Therefore, Carl Zeiss Meditec AG's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 152.84.


Carl Zeiss Meditec AG Cash Conversion Cycle Historical Data

The historical data trend for Carl Zeiss Meditec AG's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Conversion Cycle
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.14 157.38 129.03 115.54 132.39

Carl Zeiss Meditec AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.34 177.30 169.78 137.87 152.84

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Cash Conversion Cycle Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cash Conversion Cycle falls into.



Carl Zeiss Meditec AG Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Carl Zeiss Meditec AG's Cash Conversion Cycle for the fiscal year that ended in Sep. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=34.48+186.52-88.61
=132.39

Carl Zeiss Meditec AG's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=37.83+213.35-98.34
=152.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (LTS:0DHC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Carl Zeiss Meditec AG Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (LTS:0DHC) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (LTS:0DHC) Headlines

No Headlines